President Donald Trump speaks at a Nov. 20 news conference in the briefing room at the White House (Susan Walsh/AP)
December 7, 2020 04:28 PM ESTUpdated December 8, 09:41 AM
Coronavirus

Covid-19 roundup: Pfiz­er and Mod­er­na won't at­tend White House­'s 'Vac­cine Sum­mit' — re­port; Sino­vac clar­i­fies ef­fi­ca­cy num­bers

Max Gelman

Senior Editor

Though the White House is plan­ning on host­ing a “Vac­cine Sum­mit” on Tues­day, two ma­jor play­ers will not be at­tend­ing.

Pfiz­er and Mod­er­na have both …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pfiz­er look­ing to sell hos­pi­tal drugs unit — re­ports

'Ex­per­tise is a re­al thing': FDA com­mis­sion­er warns of po­lit­i­cal risk to agency

As­traZeneca CEO reaf­firms com­mit­ment to Chi­na fol­low­ing ex­ec­u­tive's de­ten­tion

Mer­ck, As­traZeneca tout Phase 3 win for can­cer-turned-rare dis­ease drug

Sanofi, Ope­nAI, For­ma­tion Bio de­but pa­tient re­cruit­ing tool, will use in Phase 3 mul­ti­ple scle­ro­sis stud­ies

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times